Theratechnologies Inc.
NASDAQ:THTX 3:59:51 PM EDT
Market Cap (Intraday) | 32.91M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $1.37 |
50-Day MA | $1.43 |
200-Day MA | $1.68 |
Theratechnologies Inc. Stock, NASDAQ:THTX
2015 Peel Street, 11th floor, Montr�©al, Qu�©bec H3A 1T8
Canada
Phone: +1.514.336.7800
Number of Employees: 114
Description
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montr�©al, Canada.